Lightnews — Scholar-powered news

CARB-X

@carb-x.bsky.social

490 followers 240 following 110 posts

A global public-private partnership led by Boston University to fund and support R&D early development of products to combat #antibioticresistance #CARBX 🔗 Visit our website: https://www.carb-x.org

www.carb-x.org

Posts Media Videos Starter Packs

Pinned

CARB-X @carb-x.bsky.social · Feb 26

📢 NEW CARB-X funding round!

🧪 Seeking #therapeutics for infections caused by Gram-negative pathogens and #diagnostics for typhoid fever for low-resource settings. Expressions of interest may be submitted from 16 April 2025 at 10:00 ET – 30 April 2025 at 23:59 ET.

🔗 bit.ly/4k8Z5uC

2 6 6

CARB-X @carb-x.bsky.social · 1h

@arrepath.bsky.social
@helmholtzhzi.bsky.social
@jlugiessen.bsky.social
@lumenbio.bsky.social
@sniprbiome.bsky.social
@thedohertyinst.bsky.social
@medschool.umaryland.edu

CARB-X @carb-x.bsky.social · 1h

@bostonu.bsky.social
@bulaw.bsky.social
@asprgov.bsky.social
@niaidnews.bsky.social
@wellcometrust.bsky.social
@gatesfoundation.bsky.social

CARB-X @carb-x.bsky.social · 1h

Thank you to 130+ attendees who convened at @imperialcollege for the 2025 CARB-X PD Conference! Clinicians, CARB-X graduates, and CARB-X R&D leaders shared innovations in therapeutics, preventatives, & diagnostics to address antibiotic resistance.

1 2

Reposted by CARB-X

LifeArc @lifearc.bsky.social · 5d

That's a wrap on #GAMRIC2025! See today's highlights over on LinkedIn - t.ly/nr1sV

Thanks to all who attended and we look forward to seeing you again next year for #GAMRIC2026.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

3 3

CARB-X @carb-x.bsky.social · 5d

That’s a wrap on the first-ever #GAMRIC2025!

Thanks to all who joined us in London to tackle AMR innovation challenges head-on—from STIs and TB to neonates and diagnostics.

Let’s keep building the future of #AMR R&D—see you at #GAMRIC2026! #CARBX #GlobalHealth

CARB-X @carb-x.bsky.social · 6d

Join CARB-X Alliance Director Betsy Wonderly Trainor at The MedTech Conference panel “The Point of Impact: Charting the Future of Decentralized Diagnostics.” 🧪 #IDSky #MTC25

📆 Monday, October 6
⏰ 9:30 – 10:30 AM PT
🔗 Register now: bit.ly/3IdS6Cs

CARB-X @carb-x.bsky.social · 6d

Day 2 at #GAMRIC2025 in London!

Today’s sessions cover:
🫁 The urgent need for new tools to treat LRTIs
🦠 TB drug discovery
🔬 The vital role of diagnostics in fighting #AMR
💡 And more!

CARB-X is proud to be part of these critical conversations. #CARBX #GlobalHealth

Reposted by CARB-X

LifeArc @lifearc.bsky.social · 7d

The inaugural Global AMR Innovators Conference (GAMRIC) has begun!

Stay tuned for updates and join the conversation here or on Bluesky using #GAMRIC2025.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

1 3 5

CARB-X @carb-x.bsky.social · 7d

Day 1 at #GAMRIC2025 in London!

Today’s sessions highlight:
🌍 The global AMR crisis
🧫 Developing therapeutics for neonatal infections
⚖️ AMR policy
💡 And more!

Proud to join researchers and funders working to address this urgent global public health challenge.

CARB-X @carb-x.bsky.social · 8d

Countdown to #GAMRIC2025: The inaugural Global AMR Innovators Conference kicks off tomorrow in London!

Join CARB-X and global leaders as we dive into discussions about #AMR policy and antimicrobial research and development. #GlobalHealth #CARBX #IDSky 🧪

1 1

CARB-X @carb-x.bsky.social · 14d

At the @eupohamr.bsky.social kickoff, CARB-X Director of External Affairs Louise Norton-Smith spoke on a panel about the importance of seeking new opportunities with partners outside the traditional AMR ecosystem to bring fresh perspectives, bridge knowledge gaps, and broaden impact.

CARB-X @carb-x.bsky.social · 15d

Register now for the 2025 BARDA Innovation Symposium! BARDA-supported innovators, other U.S. government partners, investors, and strategic partners will gather to showcase innovative technologies and network. 🧪 #IDSky
📆 Nov. 20, 2025
🔗 Register here:

2025 BARDA Innovation Symposium

Creating networking opportunities with industry and early-stage health security innovators supported by BARDA programs, including the BARDA EZ-BAA, BARDA Ventures, Blue Knight, and CARB-X

bit.ly

2 1

CARB-X @carb-x.bsky.social · 15d

💼 CARB-X is hiring a CFO!

We are looking for someone with at least eight years of experience in a senior finance role who has previously worked for nonprofits. This position is part of the CARB-X Executive Team.

➡️ Apply today! bit.ly/3YLyo5V

3 2

CARB-X @carb-x.bsky.social · 16d

Today marks the official launch of the @eupohamr.bsky.social in Brussels! CARB-X is proud to join this global partnership of over 50 organizations from 30 countries, united in a shared mission: to address the growing threat of #AMR through a truly integrated One Health approach.

1 3

CARB-X @carb-x.bsky.social · 26d

CARB-X is committed to supporting the research and development of innovative projects that could address sepsis, which is responsible for 1 in 5 deaths worldwide, according to a Lancet study published in 2020.

CARB-X @carb-x.bsky.social · 26d

Sept. 13 is #WorldSepsisDay. In 2025, several projects which aim to address bacterial infections that can lead to sepsis entered the CARB-X portfolio, including Melio, Immunartes, AstraDx, Immunethep, Baxiva, PHIOGEN, and QuantaMatrix. #IDSky 🧪
🔗 Learn more: bit.ly/4pmhiaC

1 1

CARB-X @carb-x.bsky.social · 29d

🗞️ New interview!

CARB-X Alliance Director Betsy Wonderly Trainor and QuantaMatrix Founder and CEO Sunghoon Kwon spoke with GenomeWeb about CARB-X’s recent award to QuantaMatrix and the need for rapid diagnostics for sepsis diagnoses. #IDSky 🧪

🔗 Read here:

Using Low-Cost Genetic Probes, QuantaMatrix Develops Rapid Test for Neonatal Sepsis | 360Dx

The firm will use a $2.9 million CARB-X grant to support the development of a test for species identification and drug resistance profiling within six hours.

bit.ly

1 1

CARB-X @carb-x.bsky.social · Sep 4

📘 New publication!
CARB-X Alliance Director Vega Masignani co-authored a @natureportfolio.nature.com Vaccines paper outlining early de-risking strategies for vaccine development to help accelerate vaccine R&D while reducing the likelihood of costly late-stage failures. 🧪
🔗 bit.ly/4meyxIV

CARB-X @carb-x.bsky.social · Sep 3

@bostonu.bsky.social
@bulaw.bsky.social
@asprgov.bsky.social
@niaidnews.bsky.social
@wellcometrust.bsky.social
@gatesfoundation.bsky.social

1 1

CARB-X @carb-x.bsky.social · Sep 3

CARB-X has awarded Zeteo Tech US$1M to execute a workplan for its noninvasive diagnostic platform that aims to evaluate whether exhaled breath can diagnose lower respiratory tract infections. 🧪 #IDSky

🔗 Read here: bit.ly/3HAYZgS

1 1 4

CARB-X @carb-x.bsky.social · Sep 2

This publication is a first step in CARB-X’s Portfolio Acceleration Tool intended to support the development of new decolonization agents. Colonization by drug-resistant pathogens is linked to serious infections in compromised patients.

CARB-X @carb-x.bsky.social · Sep 2

📘 New publication supported by CARB-X!

“Infection risk associated with colonization by multidrug-resistant Gram-negative bacteria: An umbrella review and meta-analysis.” 🧪 #IDSky

🔗 Read here: bit.ly/3V4tWNi

2 3 2

CARB-X @carb-x.bsky.social · Aug 28

@bostonu.bsky.social
@bulaw.bsky.social
@asprgov.bsky.social
@niaidnews.bsky.social
@wellcometrust.bsky.social
@gatesfoundation.bsky.social

CARB-X @carb-x.bsky.social · Aug 28

CARB-X has awarded QuantaMatrix US$2.85M to execute a workplan to develop its rapid diagnostic platform to detect sepsis, especially in vulnerable neonates. 🧪 #IDSky
🔗 Read here: bit.ly/45OlTsV

1 1 2

CARB-X @carb-x.bsky.social · Aug 27

Attending Queenstown Research Week?

Join CARB-X Chief Scientific Officer Richard Alm, PhD, for his presentation “CARB-X – Accelerating the Development of Novel Products to Tackle AMR.”

📆 Wednesday, September 3
⏰ 3:30 PM NZST